CytoMed Therapeutics Ltd

GDTC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873093

SEC filings (opens in a new tab)

In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.

Superinvestors holding GDTC, Q2 2026

See all superinvestors

No superinvestor reported holding GDTC in Q2 2026.